These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 18582982)

  • 1. Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging?
    Saad M; Garbuzenko OB; Ber E; Chandna P; Khandare JJ; Pozharov VP; Minko T
    J Control Release; 2008 Sep; 130(2):107-14. PubMed ID: 18582982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.
    Dharap SS; Wang Y; Chandna P; Khandare JJ; Qiu B; Gunaseelan S; Sinko PJ; Stein S; Farmanfarmaian A; Minko T
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12962-7. PubMed ID: 16123131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA.
    Taratula O; Kuzmov A; Shah M; Garbuzenko OB; Minko T
    J Control Release; 2013 Nov; 171(3):349-57. PubMed ID: 23648833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All nanocarriers are created equal.
    Park K
    J Control Release; 2008 Sep; 130(2):139. PubMed ID: 18664373
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug.
    Shah V; Taratula O; Garbuzenko OB; Taratula OR; Rodriguez-Rodriguez L; Minko T
    Clin Cancer Res; 2013 Nov; 19(22):6193-204. PubMed ID: 24036854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-Based Nanocarrier by Targeting with LHRH Peptide: A Promising Approach for Prostate Cancer Radio-Imaging and Therapy.
    De K; Tanbir SKE; Sinha S; Mukhopadhyay S
    Mol Pharm; 2024 Aug; 21(8):4128-4146. PubMed ID: 38920398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LHRH-targeted nanoparticles for cancer therapeutics.
    Minko T; Patil ML; Zhang M; Khandare JJ; Saad M; Chandna P; Taratula O
    Methods Mol Biol; 2010; 624():281-94. PubMed ID: 20217603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structure-property relationship study of the well-defined telodendrimers to improve hemocompatibility of nanocarriers for anticancer drug delivery.
    Shi C; Yuan D; Nangia S; Xu G; Lam KS; Luo J
    Langmuir; 2014 Jun; 30(23):6878-88. PubMed ID: 24849780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.
    Engel J; Emons G; Pinski J; Schally AV
    Expert Opin Investig Drugs; 2012 Jun; 21(6):891-9. PubMed ID: 22577891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of luteinizing hormone-releasing hormone-ferrosoferric oxide nanoparticles in targeted imaging of breast tumors.
    Nian D; Shi P; Sun J; Ren L; Hao X; Han J
    J Int Med Res; 2019 Apr; 47(4):1749-1757. PubMed ID: 30880516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomes.
    He Y; Zhang L; Song C
    Int J Nanomedicine; 2010 Sep; 5():697-705. PubMed ID: 20957221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting.
    Bugno J; Hsu HJ; Hong S
    J Drug Target; 2015; 23(7-8):642-50. PubMed ID: 26453160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting luteinizing hormone-releasing hormone: A potential therapeutics to treat gynecological and other cancers.
    Ghanghoria R; Kesharwani P; Tekade RK; Jain NK
    J Control Release; 2018 Jan; 269():277-301. PubMed ID: 27840168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced anti-tumoral activity of methotrexate-human serum albumin conjugated nanoparticles by targeting with Luteinizing Hormone-Releasing Hormone (LHRH) peptide.
    Taheri A; Dinarvand R; Atyabi F; Ahadi F; Nouri FS; Ghahremani MH; Ostad SN; Borougeni AT; Mansoori P
    Int J Mol Sci; 2011; 12(7):4591-608. PubMed ID: 21845098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, distribution and anti-tumor efficacy of liposomal mitoxantrone modified with a luteinizing hormone-releasing hormone receptor-specific peptide.
    Zhang L; Ren Y; Wang Y; He Y; Feng W; Song C
    Int J Nanomedicine; 2018; 13():1097-1105. PubMed ID: 29520138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibly-regulated drug release using poly(tannic acid) fabricated nanocarriers for reduced secondary side effects in tumor therapy.
    Chen C; Ma T; Tang W; Wang X; Wang Y; Zhuang J; Zhu Y; Wang P
    Nanoscale Horiz; 2020 Jun; 5(6):986-998. PubMed ID: 32322871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendronized Systems for the Delivery of Chemotherapeutics.
    Dockery L; Daniel MC
    Adv Cancer Res; 2018; 139():85-120. PubMed ID: 29941108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125.
    Seitz S; Buchholz S; Schally AV; Weber F; Klinkhammer-Schalke M; Inwald EC; Perez R; Rick FG; Szalontay L; Hohla F; Segerer S; Kwok CW; Ortmann O; Engel JB
    BMC Cancer; 2014 Nov; 14():847. PubMed ID: 25410881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery.
    Park JH; Cho HJ; Yoon HY; Yoon IS; Ko SH; Shim JS; Cho JH; Park JH; Kim K; Kwon IC; Kim DD
    J Control Release; 2014 Jan; 174():98-108. PubMed ID: 24280260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.